From BIO Boston: Adam Mendelsohn, CEO of Vivani Medical

In this episode, I sit down with Adam Mendelsohn — bioengineer turned biotech CEO — and the co-founder of Vivani Medical.

What started in a university basement has grown into a publicly listed company tackling one of the biggest challenges in healthcare: medication adherence.

We talk about:
— Building a biotech from scratch, and staying alive in tough times— Why GLP-1 implants could transform obesity and diabetes care— The mindset behind navigating clinical milestones and setbacks— And how Vivani’s platform could reshape drug delivery entirely

Adam’s story is full of grit, clarity, and ambition — and Vivani is just getting started.

This episode is part of a series of in-person interviews from BIO Boston with some of the sharpest leaders in the industry.

More to come.